This Month in Psychopharmacology

Increased Risk of Suicide Attempt in LGB Adolescents
August 7, 2017

Worldwide, the second leading cause of death amongst 15-29-year-olds is suicide, the rates of which have increased by 60% over the past 45 years...

Continue reading (Members only)

Aripiprazole Maintena Approved for Bipolar Maintenance Treatment
August 1, 2017

On July 28, 2017, the U.S. Food and Drug Administration approved the atypical antipsychotic Abilify Maintena (aripiprazole) as a maintenance monotherapy treatment for patients with Bipolar I disorder...

Continue reading (Members only)

Reducing Dementia Risk Through Lifestyle Changes: New Research
July 31, 2017

In a newly published report by The Lancet Commission, the authors review the evidence for potentially modifiable factors that may help to reduce the risk of dementia...

Continue reading (Members only)

Greater Cortical Thickness in Elderly Female Yoga Practitioners
July 22, 2017

Yoga, mind-body activity has been associated with positive changes in brain structure and function, especially in areas related to attention, executive functions, and memory. Normal aging corresponds with structural and functional brain changes, that involve decreased cognitive function. In a recent cross-sectional study...

Continue reading (Members only)

A Cross-Sectional Comparison of Brain Glucose and Ketone Metabolism in Cognitively Healthy Older Adults, Mild Cognitive Impairment (MCI) and Early Alzheimer’s Disease (AD)
July 19, 2017

Deteriorating brain glucose metabolism precedes the clinical onset of AD and contributes to its etiology. Ketone bodies, mainly ß-hydroxybutyrate and acetoacetate are the primary alternative fuel to glucose. In a recent study...

Continue reading (Members only)

Predicting the Risk of Mild Cognitive Impairment- Mayo Clinic Study of Aging
July 16, 2017

A recent longitudinal study conducted by the Mayo Clinic examined approximately 1500 participants to develop risk scores for the progression from cognitively normal (CN) to mild cognitive impairment (MCI)...

Continue reading (Members only)

Adverse Events and Limited Efficacy for Antipsychotics in Pediatric Psychosis
July 14, 2017

The treatment of psychosis in children and adolescents is perhaps more complicated and certainly less studied compared to psychosis in the adult population...

Continue reading (Members only)

Controlling Pain Without Medication: Mindfulness-Oriented Recovery Enhancement (MORE)
July 7, 2017

Long-term opioid use may lead to an increased risk of aberrant-medication related behaviors among patients who suffer from chronic pain. Risk of opioid misuse and addiction is a growing concern, but a new approach may prove to help patients suffering from both chronic pain and opioid misuse....

What's New in Tardive Dyskinesia?
June 30, 2017

Tardive dyskinesia was the focus of several sessions, lectures, and posters at the recent 2017 American Psychiatric Association (APA) Annual Meeting...

Continue reading (Members only)

Update on Substance Abuse and Addictions
June 26, 2017

At the recent 2017 American Psychiatric Association (APA) Annual Meeting, the topic of substance abuse and addiction was the focus of several sessions, lectures, and posters. Some of the highlights from the conference include...

Top of Page